Regeneron Pharmaceuticals, Inc. · NASDAQ:REGN
McCourt Marion sold 1,132 Regeneron Pharmaceuticals, Inc. shares (Form 4)
Traded Oct 30, 2026 · Filed Nov 3, 2026
On Oct 30, 2026, McCourt Marion (EVP Commercial) sold 1,132 Regeneron Pharmaceuticals, Inc. shares at US$869.43 for US$984K under a trading plan, leaving 10,871 shares. Filed Nov 3, 2026 (Form 4).
- Sold
- 1,132 shares
- Price
- US$869.43
- Value
- US$984K
- Holding after
- 10,871 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- EVP Commercial
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | Common Stock | Sale | 1,132 | US$869.43 | 10,871 | Direct |
Source
Download original · View original at SEC
Related
- Regeneron Pharmaceuticals, Inc.
- McCourt Marion
- Regeneron Pharmaceuticals, Inc. shareholders
- Form 4 · McCourt Marion · Nov 18, 2026
- Form 4 · McCourt Marion · Sep 3, 2026
- Form 4 · Murphy Andrew J · Nov 18, 2026
- Form 4 · Sing George L · Nov 18, 2026
- Form 4 · Pitofsky Jason · Nov 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Apr 30, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026